Back
Brookfield Infrastructure Partners LP Vs. Kymera Therapeutics Industry Stock Comparison
Sell
42
BIP
Brookfield Infrastructure Partners LP
Last Price:
$32.48
Seasonality Move:
2.46%
Buy
58
KYMR
Kymera Therapeutics
Last Price:
$46.41
Seasonality Move:
-8.02%
Sell
42
Brookfield Infrastructure Partners LP (BIP)
is a Sell
Is Brookfield Infrastructure Partners LP a Buy, Sell or Hold?
-
The current Brookfield Infrastructure Partners LP [BIP] share price is $32.21. The Score for BIP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
BIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $45.76. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIP Stock Price Chart
What is Brookfield Infrastructure Partners LP's stock price today?
-
The Brookfield Infrastructure Partners LP share price today is $32.21Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIP is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $45.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 39.3 | Sell |
Chaikin Money Flow: | -58439 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.4 - 33.48) | Sell |
Bollinger Bands (100): | (29.16 - 33.2) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.32 | Buy |
Relative Strength Index (14 RSI): | 57.99 | Buy |
Chaikin Money Flow: | 436230 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.33 - 46.35) | Buy |
Bollinger Bands (100): | (27.48 - 43.56) | Buy |
BIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.36 | Sell |
20-day SMA: | 32.98 | Sell |
50-day SMA: | 32.94 | Sell |
200-day SMA: | 32.37 | Sell |
8-day EMA: | 32.45 | Sell |
20-day EMA: | 32.73 | Sell |
50-day EMA: | 32.52 | Sell |
200-day EMA: | 31.87 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.4 | Buy |
20-day SMA: | 45.09 | Buy |
50-day SMA: | 41 | Buy |
200-day SMA: | 39.34 | Buy |
8-day EMA: | 42.65 | Buy |
20-day EMA: | 30.26 | Buy |
50-day EMA: | 16.11 | Buy |
200-day EMA: | 4.71 | Buy |
Brookfield Infrastructure Partners LP Earnings Growth & BIP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.21 per share, an increase this year of $0.64 per share, and an increase next year of $0.16 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.51 per share.
Brookfield Infrastructure Partners LP Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |